Agios Pharmaceuticals Inc

NASDAQ: AGIO
$45.69
+$0.28 (+0.6%)
Closing Price on September 17, 2024

AGIO Chart and Intraday Price

AGIO Company Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 88 SIDNEY STREET, CAMBRIDGE, MA, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 1,813.41M USD
Shares Outstanding 56,195,000
Agios Pharmaceuticals Inc is a pioneering biopharmaceutical company based in Cambridge, Massachusetts, focusing on creating innovative medicines that target cellular metabolism. Its flagship product, PYRUKYND, is a groundbreaking treatment for hemolytic anemias, activating specific enzymes to combat the disease. Agios is also developing treatments for myelodysplastic syndrome and phenylketonuria, alongside research into combating polycythemia vera, a rare blood disorder, through preclinical studies. Founded in 2007, Agios is at the forefront of addressing complex diseases with cutting-edge science.

AGIO Articles

Retail Earnings Fail to Rescue Broad Markets: Analysts Upgrade or Downgrade Nio, Salesforce, Target and More
Thursday’s additional top analyst upgrades and downgrades were on Advance Auto Parts, AppLovin, Nio, Norfolk Southern, Norwegian Cruise Line, Quest Diagnostics, Salesforce, Sprouts Farmers Market,...
Chris Lange
Published:

Amazon, Mastercard, Pinterest and More Friday Afternoon Analyst Upgrades and Downgrades
24/7 Wall St. looks at some big analyst upgrades and downgrades that we have seen so far on Friday, including Amazon.com, Edwards Lifesciences, Gilead Sciences, Mastercard and Pinterest.
Chris Lange
Published:

Thursday's Top Analyst Upgrades and Downgrades: AutoNation, Enbridge, Gap, JinkoSolar, Micron, Nvidia, Tractor Supply, Twilio and More
Thursday’s top analyst upgrades and downgrades included AutoNation, Enbridge, Gap, JinkoSolar, Micron Technology, Nvidia, Tractor Supply, Twilio and Vertex Pharmaceuticals.
Chris Lange
Published:

American Airlines, Biogen, Dow and More Thursday Afternoon Analyst Calls
24/7 Wall St. looks at some big analyst calls that we have seen so far on Thursday, including American Airlines, Biogen, Dow, Medtronic and Zoom Video.
Chris Lange
Published:

BioCryst, Editas, Groupon, Sunrun, Twitter and More of Monday Afternoon's Analyst Calls
24/7 Wall St. looks at some big analyst calls that we have seen so far on Monday, including BioCryst, Editas, Groupon, Sunrun, Twitter and more.
Chris Lange
Published:

Agios Pharma's Big Bet on Anemia
Agios Pharmaceuticals shares jumped on Monday after the company announced that it will be streamlining its portfolio.
Chris Lange
Published: